-
Je něco špatně v tomto záznamu ?
Ioduria and type 1 diabetes mellitus – Relationships to selected clinical markers of diabetes in adults
Michala Vosátková, Denisa Žd′árská Janíčková, Václav Zamrazil, Martina Salátová, Martin Hill, Karel Vondra
Jazyk angličtina Země Česko
Typ dokumentu práce podpořená grantem
- MeSH
- albuminurie diagnostické zobrazování MeSH
- autoprotilátky krev MeSH
- diabetes mellitus 1. typu * patofyziologie MeSH
- dospělí MeSH
- hodnoty glomerulární filtrace MeSH
- jod metabolismus moč nedostatek MeSH
- jodidperoxidasa imunologie krev MeSH
- kreatinin krev MeSH
- lidé MeSH
- thyreotropin krev MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- práce podpořená grantem MeSH
There is a lack of data on the state of iodine reserves and the possible consequences of iodine deficits in diabetic patients. The main aims of this study were to: a) obtain information about iodine saturation in patients with type 1 diabetes; b) determine to what extent this saturation differs from the non-diabetic population; and c) determine whether iodine levels are related to several clinical and laboratory parameters characteristic of diabetic syndrome, including thyroid status. Subjects and methods: A total of 54 males and 51 females treated for type 1 diabetes mellitus (DM1) were included in this cross-sectional study. In addition to iodine saturation determined as the concentration of iodine in the first urine sample of the day, we measured clinical, anthropometric, and biochemical parameters in relation to DM1. Results: Measured iodine levels were: median 152 μg/l, first quartile 117 μg/l, and third quartile 219 μg/l. More than 50% of iodine levels varied within the optimal saturation range of 100–200 μg/l, while about 14% showed incomplete saturation (<100 μg/l), and 34% had increased saturation (>200 μg/l). Multi-dimensional regression showed significant positive relationships; (an OPLS model explaining 9% of the variability) between ioduria and male sex, body weight and height, and serum creatinine levels, which to date have not yet been published. Relationships to the other analyzed parameters (glycated hemoglobin, insulin dose, DM duration, body mass index, microalbuminuria, glomerular filtration rate, thyroid function and volume, thyroid autoimmune markers) were not significant. Conclusions: Iodine saturation levels in our study group were within the ICCIDD (WHO) recommendations for optimal/good saturation for the non-diabetic population, and patients with diabetic syndrome did not differ with respect to the chosen normal ioduria concentrations, i.e. 100 or 150 μg/l. The question remains, however, whether past attempts to deal with iodine deficits in the Czech Republic are responsible for this satisfactory iodine status of the type 1 diabetic population, or if there are other factors involved.
Citace poskytuje Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17025160
- 003
- CZ-PrNML
- 005
- 20180107182956.0
- 007
- ta
- 008
- 170809s2017 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.jab.2016.11.002 $2 doi
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Vosátková, Michala $7 xx0264560 $u Institute of Endocrinology, Prague, Czech Republic
- 245 10
- $a Ioduria and type 1 diabetes mellitus – Relationships to selected clinical markers of diabetes in adults / $c Michala Vosátková, Denisa Žd′árská Janíčková, Václav Zamrazil, Martina Salátová, Martin Hill, Karel Vondra
- 504 __
- $a Literatura
- 520 9_
- $a There is a lack of data on the state of iodine reserves and the possible consequences of iodine deficits in diabetic patients. The main aims of this study were to: a) obtain information about iodine saturation in patients with type 1 diabetes; b) determine to what extent this saturation differs from the non-diabetic population; and c) determine whether iodine levels are related to several clinical and laboratory parameters characteristic of diabetic syndrome, including thyroid status. Subjects and methods: A total of 54 males and 51 females treated for type 1 diabetes mellitus (DM1) were included in this cross-sectional study. In addition to iodine saturation determined as the concentration of iodine in the first urine sample of the day, we measured clinical, anthropometric, and biochemical parameters in relation to DM1. Results: Measured iodine levels were: median 152 μg/l, first quartile 117 μg/l, and third quartile 219 μg/l. More than 50% of iodine levels varied within the optimal saturation range of 100–200 μg/l, while about 14% showed incomplete saturation (<100 μg/l), and 34% had increased saturation (>200 μg/l). Multi-dimensional regression showed significant positive relationships; (an OPLS model explaining 9% of the variability) between ioduria and male sex, body weight and height, and serum creatinine levels, which to date have not yet been published. Relationships to the other analyzed parameters (glycated hemoglobin, insulin dose, DM duration, body mass index, microalbuminuria, glomerular filtration rate, thyroid function and volume, thyroid autoimmune markers) were not significant. Conclusions: Iodine saturation levels in our study group were within the ICCIDD (WHO) recommendations for optimal/good saturation for the non-diabetic population, and patients with diabetic syndrome did not differ with respect to the chosen normal ioduria concentrations, i.e. 100 or 150 μg/l. The question remains, however, whether past attempts to deal with iodine deficits in the Czech Republic are responsible for this satisfactory iodine status of the type 1 diabetic population, or if there are other factors involved.
- 650 12
- $a diabetes mellitus 1. typu $x patofyziologie $7 D003922
- 650 _2
- $a jod $x metabolismus $x moč $x nedostatek $7 D007455
- 650 _2
- $a albuminurie $x diagnostické zobrazování $7 D000419
- 650 _2
- $a kreatinin $x krev $7 D003404
- 650 _2
- $a hodnoty glomerulární filtrace $7 D005919
- 650 _2
- $a thyreotropin $x krev $7 D013972
- 650 _2
- $a jodidperoxidasa $x imunologie $x krev $7 D007453
- 650 _2
- $a autoprotilátky $x krev $7 D001323
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a dospělí $7 D000328
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Janíčková Žďárská, Denisa $7 xx0074326 $u Department of Internal Medicine, 2nd Faculty of Medicine, Charles University in Prague, Czech Republic
- 700 1_
- $a Zamrazil, Václav, $d 1936-2018 $7 jn20000402707 $u Institute of Endocrinology, Prague, Czech Republic
- 700 1_
- $a Salátová, Martina. $7 xx0239751 $u Institute of Endocrinology, Prague, Czech Republic
- 700 1_
- $a Hill, Martin, $d 1962- $7 mzk2005304431 $u Institute of Endocrinology, Prague, Czech Republic
- 700 1_
- $a Vondra, Karel, $d 1943- $7 jo20000074105 $u Institute of Endocrinology, Prague, Czech Republic
- 773 0_
- $t Journal of applied biomedicine $x 1214-021X $g Roč. 15, č. 2 (2017), s. 146-150 $w MED00012667
- 856 41
- $u https://jab.zsf.jcu.cz/pdfs/jab/2017/02/08.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b B 2301 $c 1249 $y 4 $z 0
- 990 __
- $a 20170808075351 $b ABA008
- 991 __
- $a 20180107183206 $b ABA008
- 999 __
- $a ok $b bmc $g 1242281 $s 986081
- BAS __
- $a 3
- BMC __
- $a 2017 $b 15 $c 2 $d 146-150 $i 1214-021X $m Journal of Applied Biomedicine $x MED00012667
- LZP __
- $c NLK125 $d 20180107 $a NLK 2017-37/vt